Glooko Raises $30 Million Financing Round 16 marzo 2021 | 12.01
New Capital Reflects the Company s Increasing Trajectory and Market Growth
PALO ALTO, Calif., March 16, 2021 /PRNewswire/ Glooko Inc., a leading provider of remote patient monitoring and chronic care management solutions including diabetes and obesity has raised a $30 million Series D round of funding. The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. Proceeds will be used to accelerate organic growth and strategic initiatives across the company s broad and growing product line of advanced digital health solutions. Glooko has done a remarkable job of bringing to market cutting edge digital healthcare platforms, which empower people with diabetes to better manage their disease and improve their lives. This technology enables physicians to take better care of patients with diabetes by strengt